Articles liés à Good Genes Gone Bad: A Short History of Vaccines and...
Good Genes Gone Bad: A Short History of Vaccines and Biologics: Failures, Successes, Controversies - Couverture rigide
Synopsis
The field of biotechnology has evolved over the past four decades, developing medicines which are curing diseases. But this journey of success has been tough and arduous, built upon the shoulders of major failures.
Good Genes Gone Bad highlights seven such colossal failures in drug development-all of which culminated in the development of novel drugs-weaving together various analogies through the stories and thus allowing the reader to understand complex biological phenomena. These stories include treatment of medical conditions such as genetic clotting disorder (haemophilia), childhood-diarrhoea (rotavirus vaccine), preventing HIV infection, activation of the immune systems to treat cancer, gene therapy for treatment of diseases caused by gene-defects/mutations, cell therapy for treatment of leukaemias, and finally the success of Biocon's approval of the first biologic drug for breast cancer.
Written by the former R&D head of Biocon, India's largest pharmaceutical company, Good Genes Gone Bad is a fascinating look at the complex world of medicine and drug development, providing the readers with a sense of magnitude of challenges and the extent of difficulty that it takes to make novel medicines.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
À propos de l'auteur
Narendra Chirmule, PhD, is the founder-director of SymphonyTech Biologics, a company focused on statistical, technical and quality aspects in drug development. Most recently, he was head of R&D at Biocon Research Labs, Bangalore, one of India's largest biotechnology companies. Under his leadership, the company received the first ever approvals of biologics by FDA and EMA in India.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour Good Genes Gone Bad: A Short History of Vaccines and...
Image d'archives
Good Genes Gone Bad : A Short History of Vaccines and Biological Drugs That Have Transformed Medicine
Edité par
Ebury Publishing, 2022
ISBN 10 : 0670096032
ISBN 13 : 9780670096039
Ancien ou d'occasion
Couverture rigide
Vendeur : Better World Books: West, Reno, NV, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : Very Good. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. N° de réf. du vendeur 57824863-75
Acheter D'occasion
EUR 10,07
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs that Have Transformed Medicine
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. pp. 304. N° de réf. du vendeur 379152480
Acheter neuf
EUR 12,57
Expédition à EUR 7,75
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Good Genes Gone Bad
Edité par
Penguin Random House India, IN, 2021
ISBN 10 : 0670096032
ISBN 13 : 9780670096039
Neuf
Couverture rigide
Vendeur : Rarewaves USA, HEBRON, KY, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Hardback. Etat : New. The field of biotechnology has evolved over the past four decades, developing medicines which are curing diseases. But this journey of success has been tough and arduous, built upon the shoulders of major failures. Good Genes Gone Bad highlights seven such colossal failures in drug development-all of which culminated in the development of novel drugs-weaving together various analogies through the stories and thus allowing the reader to understand complex biological phenomena. These stories include treatment of medical conditions such as genetic clotting disorder (haemophilia), childhood-diarrhoea (rotavirus vaccine), preventing HIV infection, activation of the immune systems to treat cancer, gene therapy for treatment of diseases caused by gene-defects/mutations, cell therapy for treatment of leukaemias, and finally the success of Biocon's approval of the first biologic drug for breast cancer. Written by the former RandD head of Biocon, India's largest pharmaceutical company, Good Genes Gone Bad is a fascinating look at the complex world of medicine and drug development, providing the readers with a sense of magnitude of challenges and the extent of difficulty that it takes to make novel medicines. N° de réf. du vendeur LU-9780670096039
Acheter neuf
EUR 20,50
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 5 disponible(s)
Image d'archives
Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs that Have Transformed Medicine
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. pp. 304. N° de réf. du vendeur 26384751551
Acheter neuf
EUR 18,52
Expédition à EUR 3,55
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Good Genes Gone Bad: A Short History of Vaccines and Biological Drugs that Have Transformed Medicine
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. pp. 304. N° de réf. du vendeur 18384751541
Acheter neuf
EUR 12,23
Expédition à EUR 9,95
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 10 disponible(s)
Image d'archives
GOOD GENES GONE BAD : A SHORT HISTORY OF VACCINES AND BIOLIGICS: FAILURES, SUCCESSES, CONTROVERSIES
Vendeur : Basi6 International, Irving, TX, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. N° de réf. du vendeur ABEOCT25-355541
Acheter neuf
EUR 30,47
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 5 disponible(s)
Image fournie par le vendeur
Good Genes Gone Bad
Edité par
Penguin Random House India, IN, 2021
ISBN 10 : 0670096032
ISBN 13 : 9780670096039
Neuf
Couverture rigide
Vendeur : Rarewaves USA United, HEBRON, KY, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Hardback. Etat : New. The field of biotechnology has evolved over the past four decades, developing medicines which are curing diseases. But this journey of success has been tough and arduous, built upon the shoulders of major failures. Good Genes Gone Bad highlights seven such colossal failures in drug development-all of which culminated in the development of novel drugs-weaving together various analogies through the stories and thus allowing the reader to understand complex biological phenomena. These stories include treatment of medical conditions such as genetic clotting disorder (haemophilia), childhood-diarrhoea (rotavirus vaccine), preventing HIV infection, activation of the immune systems to treat cancer, gene therapy for treatment of diseases caused by gene-defects/mutations, cell therapy for treatment of leukaemias, and finally the success of Biocon's approval of the first biologic drug for breast cancer. Written by the former RandD head of Biocon, India's largest pharmaceutical company, Good Genes Gone Bad is a fascinating look at the complex world of medicine and drug development, providing the readers with a sense of magnitude of challenges and the extent of difficulty that it takes to make novel medicines. N° de réf. du vendeur LU-9780670096039
Acheter neuf
EUR 17,44
Expédition à EUR 44,51
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 5 disponible(s)